FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090814529> ?p ?o ?g. }

• W2090814529 endingPage "630" @default.
• W2090814529 startingPage "625" @default.
• W2090814529 abstract "Background/AimsOrthotopic liver transplantation (OLT) is an important therapeutic option for HBV-related end-stage-liver disease, yet it is often hampered by a scarcity of organ availability. One option to increase organ availability is the use of virologically compromised organs from HBV-infected donors. Transplantation of anti-HBcore positive grafts has been associated with a low risk of HBV recurrence if adequately treated with nucleoside analogs, irrespective of concomitant HBV-specific immunoglobulin therapy. Experience using HBsAg positive grafts is, however, very limited.MethodsHere, the analysis of the cellular and humoral HBV-specific immunity of a subject with past HBV infection (anti-HBs and anti-HBc positive) receiving an HBsAg positive liver graft is reported.ResultsNine months post-OLT, the patient experienced a spontaneous anti-HBs re-seroconversion allowing the discontinuation of HBIG. The data show a concurrent increase in the cellular and humoral immunity at times of reduced viral antigenemia, demonstrating effective immune control of HBV post-OLT.ConclusionsThese data support the use of marginal organs in this setting, providing a potential strategy to further alleviate organ shortage. Orthotopic liver transplantation (OLT) is an important therapeutic option for HBV-related end-stage-liver disease, yet it is often hampered by a scarcity of organ availability. One option to increase organ availability is the use of virologically compromised organs from HBV-infected donors. Transplantation of anti-HBcore positive grafts has been associated with a low risk of HBV recurrence if adequately treated with nucleoside analogs, irrespective of concomitant HBV-specific immunoglobulin therapy. Experience using HBsAg positive grafts is, however, very limited. Here, the analysis of the cellular and humoral HBV-specific immunity of a subject with past HBV infection (anti-HBs and anti-HBc positive) receiving an HBsAg positive liver graft is reported. Nine months post-OLT, the patient experienced a spontaneous anti-HBs re-seroconversion allowing the discontinuation of HBIG. The data show a concurrent increase in the cellular and humoral immunity at times of reduced viral antigenemia, demonstrating effective immune control of HBV post-OLT. These data support the use of marginal organs in this setting, providing a potential strategy to further alleviate organ shortage." @default.
• W2090814529 created "2016-06-24" @default.
• W2090814529 creator A5000508933 @default.
• W2090814529 creator A5001100012 @default.
• W2090814529 creator A5012963385 @default.
• W2090814529 creator A5020323314 @default.
• W2090814529 creator A5054595226 @default.
• W2090814529 creator A5057503092 @default.
• W2090814529 creator A5062155863 @default.
• W2090814529 creator A5067697245 @default.
• W2090814529 creator A5079443706 @default.
• W2090814529 creator A5087296098 @default.
• W2090814529 creator A5089713793 @default.
• W2090814529 creator A5090367243 @default.
• W2090814529 date "2009-03-01" @default.
• W2090814529 modified "2023-10-16" @default.
• W2090814529 title "Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft" @default.
• W2090814529 cites W1974424516 @default.
• W2090814529 cites W1977520603 @default.
• W2090814529 cites W1979654640 @default.
• W2090814529 cites W1985565097 @default.
• W2090814529 cites W1985970818 @default.
• W2090814529 cites W1989364161 @default.
• W2090814529 cites W1993593317 @default.
• W2090814529 cites W1997047331 @default.
• W2090814529 cites W2015071219 @default.
• W2090814529 cites W2022051161 @default.
• W2090814529 cites W2040252821 @default.
• W2090814529 cites W2061832920 @default.
• W2090814529 cites W2076480509 @default.
• W2090814529 cites W2081953941 @default.
• W2090814529 cites W2095238191 @default.
• W2090814529 cites W2112865435 @default.
• W2090814529 cites W2123811267 @default.
• W2090814529 cites W2130204967 @default.
• W2090814529 cites W2148582116 @default.
• W2090814529 cites W2157314577 @default.
• W2090814529 cites W2159170119 @default.
• W2090814529 cites W2166198720 @default.
• W2090814529 cites W4245991025 @default.
• W2090814529 doi "https://doi.org/10.1016/j.jhep.2008.08.026" @default.
• W2090814529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19157623" @default.
• W2090814529 hasPublicationYear "2009" @default.
• W2090814529 type Work @default.
• W2090814529 sameAs 2090814529 @default.
• W2090814529 citedByCount "42" @default.
• W2090814529 countsByYear W20908145292012 @default.
• W2090814529 countsByYear W20908145292013 @default.
• W2090814529 countsByYear W20908145292014 @default.
• W2090814529 countsByYear W20908145292015 @default.
• W2090814529 countsByYear W20908145292016 @default.
• W2090814529 countsByYear W20908145292017 @default.
• W2090814529 countsByYear W20908145292018 @default.
• W2090814529 countsByYear W20908145292019 @default.
• W2090814529 countsByYear W20908145292020 @default.
• W2090814529 countsByYear W20908145292021 @default.
• W2090814529 countsByYear W20908145292022 @default.
• W2090814529 crossrefType "journal-article" @default.
• W2090814529 hasAuthorship W2090814529A5000508933 @default.
• W2090814529 hasAuthorship W2090814529A5001100012 @default.
• W2090814529 hasAuthorship W2090814529A5012963385 @default.
• W2090814529 hasAuthorship W2090814529A5020323314 @default.
• W2090814529 hasAuthorship W2090814529A5054595226 @default.
• W2090814529 hasAuthorship W2090814529A5057503092 @default.
• W2090814529 hasAuthorship W2090814529A5062155863 @default.
• W2090814529 hasAuthorship W2090814529A5067697245 @default.
• W2090814529 hasAuthorship W2090814529A5079443706 @default.
• W2090814529 hasAuthorship W2090814529A5087296098 @default.
• W2090814529 hasAuthorship W2090814529A5089713793 @default.
• W2090814529 hasAuthorship W2090814529A5090367243 @default.
• W2090814529 hasBestOaLocation W20908145292 @default.
• W2090814529 hasConcept C126322002 @default.
• W2090814529 hasConcept C159654299 @default.
• W2090814529 hasConcept C168444539 @default.
• W2090814529 hasConcept C203014093 @default.
• W2090814529 hasConcept C2522874641 @default.
• W2090814529 hasConcept C2776543447 @default.
• W2090814529 hasConcept C2777075537 @default.
• W2090814529 hasConcept C2777333352 @default.
• W2090814529 hasConcept C2777382497 @default.
• W2090814529 hasConcept C2777410769 @default.
• W2090814529 hasConcept C2777451964 @default.
• W2090814529 hasConcept C2779384505 @default.
• W2090814529 hasConcept C2779609443 @default.
• W2090814529 hasConcept C2780593183 @default.
• W2090814529 hasConcept C2911091166 @default.
• W2090814529 hasConcept C55493867 @default.
• W2090814529 hasConcept C71924100 @default.
• W2090814529 hasConcept C86803240 @default.
• W2090814529 hasConceptScore W2090814529C126322002 @default.
• W2090814529 hasConceptScore W2090814529C159654299 @default.
• W2090814529 hasConceptScore W2090814529C168444539 @default.
• W2090814529 hasConceptScore W2090814529C203014093 @default.
• W2090814529 hasConceptScore W2090814529C2522874641 @default.
• W2090814529 hasConceptScore W2090814529C2776543447 @default.
• W2090814529 hasConceptScore W2090814529C2777075537 @default.
• W2090814529 hasConceptScore W2090814529C2777333352 @default.
• W2090814529 hasConceptScore W2090814529C2777382497 @default.

• next